Extended-release naltrexone initiated after just five to seven days of seeking treatment is more effective than starting treatment after the traditional interim stage of 10 to 15 days.
Study finds that postpartum depression is underdiagnosed in those reporting symptoms up to a year after giving birth, with Black and Asian individuals least likely to receive treatment.
Columbia psychologist Erin K. Engle discusses the signs that indicate the time is right to stop therapy and questions patients should ask themselves before moving on.
Prescriptions of stimulants and antidepressants for children do not appear to be prescribed at rates higher than the known rates for ADHD and depression.
A new study suggests a smell test can identify people with mild cognitive impairment–often a precursor to Alzheimer’s–who may benefit from cholinesterase inhibitors.
From 2005 to 2015, depression rose significantly among Americans age 12 and older, according to researchers at the Mailman School of Public Health and CUNY.